SUBCUTANEOUS DRUG DELIVERY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

Technological innovations and developments in prefilled syringes and auto-injectors is contributing to the market growth. For instance, Gerresheimer, German manufacturer of primary packaging introduced metal-free Lure Lock Gx RTF Syringe in June 2020, without tungsten to create the perfect primary packaging material for biotechnologically manufactured active ingredients that ideally exclude the possibility of contamination with metal.

Moreover, in March 2022, YpsoMed, medical device companies developed YpsoMate SmartPilot, a reusable attachment to its proprietary YpsoMate pen, which is designed for an easy two-step injection process. The device has a sensor and memory, which is connected to an app, which displays injection timing and doses. The pen provides audio and visual feedback to users. The app can also remind users when it is time to inject the insulin.

Market Dynamics

Product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, on March 6, 2023, Coherus BioSciences, Inc, its global biosimilar company, announced U.S. Food and Drug Administration (FDA) approved a single-dose, prefilled auto injector presentation of UDENYCA (pegfilgrastim-cbqv). The UDENYCA autoinjector has a streamlined, easy-to-use design for use in both in-office and at-home settings of care.

Key features of the study:

• This report provides in-depth analysis of the global subcutaneous drug delivery market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
• It profiles key players in the global subcutaneous drug delivery market based on the following parameters–company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Becton Dickinson and Company, Novo Nordisk A/S, Johnson & Johnson, Inc., Novartis International AG, Amgen, Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche AG, Consort Medical plc, Eli Lilly and Company, Merck & Co., Inc., Insulet Corporation, West Pharmaceutical Services, Inc Gerresheimer AG and other prominent key players.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• Global subcutaneous drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global subcutaneous drug delivery market

Detailed Segmentation:

• Global Subcutaneous Drug Delivery Market, Usability
  • Disposable
  • Reusable
• Global Subcutaneous Drug Delivery Market, Disease Indication
  • Auto-immune Disorders
  • Neurological Disorders
  • Oncology Disorders
  • Hormonal Disorders
  • Allergy & Infectious Disorders
  • Ophthalmic Disorders
  • Others
• Global Subcutaneous Drug Delivery Market, Delivery System
  • Prefilled Syringes
  • Autoinjector
    • Spring Type
    • Motorized Type
    • Wearable Type
  • Pen Injectors
    • Disposable
    • Reusable
    • Syringes (Injector)
  • Others (pump, etc.)
• Global Subcutaneous Drug Delivery Market, By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Subcutaneous Drug Delivery Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country:
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Becton Dickinson and Company,
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novo Nordisk A/S,
  • Johnson & Johnson
  • Novartis International AG
  • Amgen, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • F. Hoffmann-La Roche AG.,
  • Consort Medical plc,
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Insulet Corporation,
  • West Pharmaceutical Services, Inc.
  • Gerresheimer AG

“*” marked represents similar segmentation in other categories in the respective section.